Many Americans won't benefit from Eli Lilly's insulin price cut

When drugmaker Eli Lilly announced it was slashing the cost of insulin and capping out-of-pocket costs to just $35 a month, it was major news. But, Eli Lilly only has 23% of the insulin market and that means millions of Americans saw those gaudy headlines and were left asking, "what about me?” Nicole Gambino is one of the more than 37 million Americans with diabetes. She was diagnosed with type one diabetes in middle school.